News | September 20, 2013

New York Proton Consortium Expands Access To Proton Therapy Through Agreement With Procure Proton Therapy Center In New Jersey

The New York Proton Center (NYPC), a consortium of five leading hospitals in New York City, including Continuum Health Partners, Memorial Sloan-Kettering Cancer Center, Montefiore Medical Center, the Mount Sinai Medical Center, and New York University Langone Medical Center, announced an agreement with ProCure Proton Therapy Center in Somerset, N.J., CentraState Health Care System, Princeton Radiation Oncology  and management services for NYPC being provided by 21st Century Oncology, a national provider of advanced radiation oncology services. This agreement will give the consortium’s patients access to a state-of-the-art proton treatment center in Somerset, N.J., one of only twelve such centers in the nation and the only center in the New York and New Jersey region. Proton therapy is a unique form of precision radiation that directly attacks tumors while minimizing potentially damaging radiation to surrounding healthy tissues and organs.

The NYPC consortium noted in a brief statement that they are "deeply committed to providing the highest standard of care to cancer patients, which includes access to proton therapy. For certain patients, especially those with solid tumors surrounded by sensitive tissue and vital organs, proton therapy is often the treatment of choice."   

Studies have shown proton therapy to be effective in treating many types of tumors, including pediatric cancers and selected tumors of the head and neck, brain, spinalcord, breast, gastrointestinal system, lung and prostate.

Unlike traditional X-ray beams that deposit a dose of radiation all the way through the patient’s body, proton beams stop abruptly and do not deliver radiation dose beyond the tumor.  In many cases, this unique property of protons allows physicians to concentrate radiation within the tumor while reducing the dose to surrounding tissues with greater precision than can be achieved with conventional radiation beams, thereby reducing the risk of side effects and improving the patient’s quality of life.  

Recognizing these benefits of proton therapy for patients with specific tumor types, NYPC’s agreement with the ProCure Proton Therapy Center allows this therapy to be conveniently accessible for their patients. Under the agreement, patients receiving care at NYPC hospitals who need proton therapy will continue to have their treatments provided by their physicians who will now have treatment privileges at the Proton Center.

“It has always been the Mission of ProCure and our affiliate CentraState Healthcare System to make proton therapy available to as many patients as possible,” said Oren Cahlon, M.D., of Princeton Radiation Oncology, medical director of the ProCure Proton Therapy Center in Somerset, N.J. “Our agreement with NYPC allows us to share our access to proton therapy and takes us one step closer to fulfilling our mission.”

The ProCure Proton Therapy Center in Somerset, N.J., in affiliation with CentraState Healthcare System and Princeton Radiation Oncology, opened in March 2012.

For more information: www.procure.com

Related Content

DOSIsoft Releases ISOgray Proton Therapy Treatment Planning System
Technology | Treatment Planning | August 15, 2017
DOSIsoft SA announced the official release, with CE marking, of ISOgray Treatment Planning System (TPS) release 4.3 for...
Eight Proton Therapy Centers Worldwide Adopt RayStation for Treatment Planning
News | Treatment Planning | July 21, 2017
RaySearch Laboratories reported that eight additional proton therapy centers worldwide have recently chosen RayStation...
IBA to Install Proton Therapy Facility at Inova Schar Cancer Institute
News | Proton Therapy | July 18, 2017
IBA (Ion Beam Applications S.A.) and Inova recently signed a contract for a two-room Proteus Plus proton therapy...
Proton International and Beaumont Health Open Michigan's First Proton Therapy Facility
News | Proton Therapy | July 17, 2017
Proton International (PI) and Beaumont Health recently opened the state’s first proton therapy center, offering the...
ASTRO Updates Insurance Coverage Recommendations for Proton Therapy
News | Proton Therapy | July 17, 2017
The American Society for Radiation Oncology (ASTRO) has issued an update to its recommendations for medical insurance...
IBA and Philips Step Up Commercial Collaboration in Brazilian Proton Therapy Market
News | Radiation Therapy | July 03, 2017
IBA and Philips announced in mid-June they are stepping up their combined effort for proton therapy in Brazil.
First Patient Treated With Pencil Beam Scanning at Institute Curie Proton Therapy Center
News | Proton Therapy | May 23, 2017
May 23, 2017 — IBA announced that the first patient has been treated with pencil beam scanning (PBS) technology at th
News | Radiation Therapy | May 16, 2017
Proton International announced the successful financing of a new state-of-the-art radiation therapy center and a...
Proton Monte Carlo Dose Calculation Now Part of RayStation Treatment Planning
News | Treatment Planning | May 15, 2017
RaySearch demonstrated a new Monte Carlo dose planning feature for proton therapy on its RayStation system at the 2017...
Work Starts on Belgium's First Proton Therapy Center
News | Proton Therapy | May 05, 2017
IBA announced that building works have begun on the Proton Therapy Center ParTICLe – Belgium’s first center for proton...
Overlay Init